This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (219)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Metabolic Diseases  • Alert me on articles by topic

Gang Hu, MD; Qing Qiao, MD; Jaakko Tuomilehto, MD; Beverley Balkau, MD; Knut Borch-Johnsen, MD; Kalevi Pyorala, MD; for the DECODE Study Group

Arch Intern Med. 2004;164:1066-1076.

Background  Few studies have evaluated the associations between the metabolic syndrome (by any definition) and mortality. This study examined the age- and sex-specific prevalence of the metabolic syndrome and its association with all-cause and cardiovascular mortality in nondiabetic European men and women.

Methods  The study was based on 11 prospective European cohort studies comprising 6156 men and 5356 women without diabetes and aged from 30 to 89 years, and had a median follow-up of 8.8 years. A modification of the World Health Organization definition of the metabolic syndrome was used. The subjects were considered to have the metabolic syndrome if they had hyperinsulinemia and 2 or more of the following: obesity, hypertension, dyslipidemia, or impaired glucose regulation; however, other definitions were also studied. Hazard ratios for all-cause and cardiovascular mortality were estimated with Cox models in each cohort. Meta-analyses were performed to assess the overall association of the metabolic syndrome with mortality risk.

Results  The age-standardized prevalence of the metabolic syndrome was slightly higher in men (15.7%) than in women (14.2%). Of the 1119 deaths recorded during follow-up, 432 were caused by cardiovascular disease. The overall hazard ratios for all-cause and cardiovascular mortality in persons with the metabolic syndrome compared with persons without it were 1.44 (95% confidence interval [CI], 1.17-1.84) and 2.26 (95% CI, 1.61-3.17) in men and 1.38 (95% CI, 1.02-1.87) and 2.78 (95% CI, 1.57-4.94) in women after adjustment for age, blood cholesterol levels, and smoking.

Conclusions  The overall prevalence of the metabolic syndrome in nondiabetic adult Europeans is 15%. Nondiabetic persons with the metabolic syndrome have an increased risk of death from all causes as well as cardiovascular disease.

From the Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland. The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Metabolic Syndrome and Cardiovascular Mortality in Older Type 2 Diabetic Patients: A Longitudinal Study
Monami et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2008;63:646-649.
ABSTRACT | FULL TEXT  

Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome
Bratz et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2489-H2496.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study
Mozaffarian et al.
Arch Intern Med 2008;168:969-978.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland
Wang et al.
Stroke 2008;39:1078-1083.
ABSTRACT | FULL TEXT  

Metabolic syndrome and the menopause
Kaaja
Menopause Int 2008;14:21-25.
ABSTRACT | FULL TEXT  

The Increasing Prevalence of Metabolic Syndrome among Finnish Men and Women over a Decade
Hu et al.
J. Clin. Endocrinol. Metab. 2008;93:832-836.
ABSTRACT | FULL TEXT  

Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?: A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects
Musso et al.
Diabetes Care 2008;31:562-568.
ABSTRACT | FULL TEXT  

Elevated Gamma-Glutamyltransferase Activity and Perturbed Thiol Profile Are Associated With Features of Metabolic Syndrome
Giral et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:587-593.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study
Boden-Albala et al.
Stroke 2008;39:30-35.
ABSTRACT | FULL TEXT  

Low Urine pH: A Novel Feature of the Metabolic Syndrome
Maalouf et al.
CJASN 2007;2:883-888.
ABSTRACT | FULL TEXT  

All-Cause Mortality Associated With Specific Combinations of the Metabolic Syndrome According to Recent Definitions
Guize et al.
Diabetes Care 2007;30:2381-2387.
ABSTRACT | FULL TEXT  

Body Mass Index, Waist Circumference, and Waist-Hip Ratio on the Risk of Total and Type-Specific Stroke
Hu et al.
Arch Intern Med 2007;167:1420-1427.
ABSTRACT | FULL TEXT  

Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans?
Blaum et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:766-773.
ABSTRACT | FULL TEXT  

Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study
Ninomiya et al.
Stroke 2007;38:2063-2069.
ABSTRACT | FULL TEXT  

Flow-Induced Remodeling in Resistance Arteries From Obese Zucker Rats Is Associated With Endothelial Dysfunction
Bouvet et al.
Hypertension 2007;50:248-254.
ABSTRACT | FULL TEXT  

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT  

Relationship Between Metabolic Risk Factor Clustering and Cardiovascular Mortality Stratified by High Blood Glucose and Obesity: NIPPON DATA90, 1990-2000
Kadota et al.
Diabetes Care 2007;30:1533-1538.
ABSTRACT | FULL TEXT  

Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study
Jeppesen et al.
J Am Coll Cardiol 2007;49:2112-2119.
ABSTRACT | FULL TEXT  

Different Waist Circumferences, Different Metabolic Risks in Koreans
Joo et al.
J Am Board Fam Med 2007;20:258-265.
ABSTRACT | FULL TEXT  

Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I
Empana et al.
Eur Heart J 2007;28:1149-1154.
ABSTRACT | FULL TEXT  

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns
Wang et al.
Eur Heart J 2007;28:857-864.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome and the Carotid Artery Structure in Noninstitutionalized Elderly Subjects: The Three-City Study
Empana et al.
Stroke 2007;38:893-899.
ABSTRACT | FULL TEXT  

Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Kidambi et al.
Hypertension 2007;49:704-711.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies
Gami et al.
J Am Coll Cardiol 2007;49:403-414.
ABSTRACT | FULL TEXT  

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT  

Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis
Mancia et al.
Hypertension 2007;49:40-47.
ABSTRACT | FULL TEXT  

Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome
Esmaillzadeh et al.
Am. J. Clin. Nutr. 2006;84:1489-1497.
ABSTRACT | FULL TEXT  

Uric Acid, the Metabolic Syndrome, and Renal Disease
Cirillo et al.
J. Am. Soc. Nephrol. 2006;17:S165-S168.
ABSTRACT | FULL TEXT  

PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences
Alessi and Juhan-Vague
Arterioscler. Thromb. Vasc. Bio. 2006;26:2200-2207.
ABSTRACT | FULL TEXT  

Background and treatment of metabolic syndrome: a therapeutic challenge.
van Zwieten and Mancia
SEMIN CARDIOTHORAC VASC ANESTH 2006;10:206-214.
ABSTRACT  

Cholesterol and Glucose Metabolism and Recurrent Cardiovascular Events Among the Elderly: A Prospective Study
Strandberg et al.
J Am Coll Cardiol 2006;48:708-714.
ABSTRACT | FULL TEXT  

Prevalence of Cardiovascular Disease Risk Factors in U.S. Children and Adolescents With Diabetes: The SEARCH for Diabetes in Youth Study
Rodriguez et al.
Diabetes Care 2006;29:1891-1896.
ABSTRACT | FULL TEXT  

Clinical Use of the Metabolic Syndrome: Why the Confusion?
Blaha and Elasy
Clin. Diabetes 2006;24:125-131.
ABSTRACT | FULL TEXT  

Insulin Resistance and Atherosclerosis
Nigro et al.
Endocr. Rev. 2006;27:242-259.
ABSTRACT | FULL TEXT  

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
Sundstrom et al.
BMJ 2006;332:878-882.
ABSTRACT | FULL TEXT  

Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.
Natali et al.
Diabetes 2006;55:1133-1140.
ABSTRACT | FULL TEXT  

Association between the metabolic syndrome and parental history of premature cardiovascular disease
Dallongeville et al.
Eur Heart J 2006;27:722-728.
ABSTRACT | FULL TEXT  

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Poirier et al.
Circulation 2006;113:898-918.
ABSTRACT | FULL TEXT  

Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial
Eberly et al.
Diabetes Care 2006;29:123-130.
ABSTRACT | FULL TEXT  

Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women
Mellen et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:189-193.
ABSTRACT | FULL TEXT  

Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
Wannamethee et al.
Arch Intern Med 2005;165:2644-2650.
ABSTRACT | FULL TEXT  

A COmparative study with rosuvastatin in subjects with METabolic Syndrome: results of the COMETS study
Stalenhoef et al.
Eur Heart J 2005;26:2664-2672.
ABSTRACT | FULL TEXT  

Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents
Klein-Platat et al.
Am. J. Clin. Nutr. 2005;82:1178-1184.
ABSTRACT | FULL TEXT  

Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Wilson et al.
Circulation 2005;112:3066-3072.
ABSTRACT | FULL TEXT  

Increased Mortality Associated With the Metabolic Syndrome in Older Women With Diabetes
Hillier et al.
Diabetes Care 2005;28:2258-2260.
FULL TEXT  

An Exploratory Analysis of Criteria for the Metabolic Syndrome and Its Prediction of Long-term Cardiovascular Outcomes: The Hoorn Study
Girman et al.
Am J Epidemiol 2005;162:438-447.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker et al.
Circulation 2005;112:666-673.
ABSTRACT | FULL TEXT  

Cardiorespiratory Fitness Is Inversely Associated With the Incidence of Metabolic Syndrome: A Prospective Study of Men and Women
LaMonte et al.
Circulation 2005;112:505-512.
ABSTRACT | FULL TEXT  

Hyperglycemia, Lipoprotein Glycation, and Vascular Disease
Veiraiah
ANGIOLOGY 2005;56:431-438.
ABSTRACT  

Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Dokras et al.
Obstet Gynecol 2005;106:131-137.
ABSTRACT | FULL TEXT  

Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome: A summary of the evidence
Ford
Diabetes Care 2005;28:1769-1778.
ABSTRACT | FULL TEXT  

Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial
Geluk et al.
Eur Heart J 2005;26:1314-1320.
ABSTRACT | FULL TEXT  

Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack: A Prospective Cohort Study in Patients With Atherosclerotic Cardiovascular Disease
Koren-Morag et al.
Stroke 2005;36:1366-1371.
ABSTRACT | FULL TEXT  

Is the Diagnosis of Metabolic Syndrome Useful for Predicting Cardiovascular Disease in Asian Diabetic Patients?: Analysis from the Japan Diabetes Complications Study
Sone et al.
Diabetes Care 2005;28:1463-1471.
ABSTRACT | FULL TEXT  

Strategies for the prevention of type 2 diabetes and cardiovascular disease
Tuomilehto et al.
Eur Heart J Suppl 2005;7:D18-D22.
FULL TEXT  

Metabolic Syndrome Is Associated With Aortic Stiffness in Untreated Essential Hypertension
Schillaci et al.
Hypertension 2005;45:1078-1082.
ABSTRACT | FULL TEXT  

Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
Enzinger et al.
Neurology 2005;64:1704-1711.
ABSTRACT | FULL TEXT  

Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes: A meta-analysis of clinical studies
Vettor et al.
Diabetes Care 2005;28:942-949.
ABSTRACT | FULL TEXT  

Components of the Metabolic Syndrome and Carotid Atherosclerosis: Role of Elevated Blood Pressure
Irace et al.
Hypertension 2005;45:597-601.
ABSTRACT | FULL TEXT  

Effects of exercise and diet on chronic disease
Roberts and Barnard
J. Appl. Physiol. 2005;98:3-30.
ABSTRACT | FULL TEXT  

Aerobic power and insulin action improve in response to endurance exercise training in healthy 77-87 yr olds
Evans et al.
J. Appl. Physiol. 2005;98:40-45.
ABSTRACT | FULL TEXT  

Low-Grade Inflammation and Microalbuminuria in Hypertension
Pedrinelli et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:2414-2419.
ABSTRACT | FULL TEXT  

Prevalence and Trends of a Metabolic Syndrome Phenotype Among U.S. Adolescents, 1999-2000
Duncan et al.
Diabetes Care 2004;27:2438-2443.
ABSTRACT | FULL TEXT